WEREWOLF THERAPEUTICS INC's ticker is HOWL and the CUSIP is 95075A107. A total of 44 filers reported holding WEREWOLF THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,119,006 | -29.8% | 522,900 | 0.0% | 0.01% | -22.2% |
| Q2 2023 | $1,594,845 | +17.3% | 522,900 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $1,359,540 | +26.8% | 522,900 | 0.0% | 0.01% | +80.0% |
| Q4 2022 | $1,071,945 | -54.5% | 522,900 | 0.0% | 0.01% | -64.3% |
| Q3 2022 | $2,358,000 | +7.7% | 522,900 | -2.3% | 0.01% | -58.8% |
| Q2 2022 | $2,189,000 | – | 535,160 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DC Funds, LP | 589,102 | $1,796,761 | 38.27% |
| MPM ASSET MANAGEMENT LLC | 4,284,172 | $13,066,725 | 6.41% |
| MPM BioImpact LLC | 2,388,011 | $7,283,434 | 1.47% |
| RA Capital Management | 6,144,881 | $18,741,887 | 0.35% |
| SPHERA FUNDS MANAGEMENT LTD. | 626,810 | $1,911,771 | 0.30% |
| PFM Health Sciences, LP | 2,303,891 | $7,026,868 | 0.27% |
| Rubric Capital Management LP | 1,935,357 | $5,902,839 | 0.25% |
| Alyeska Investment Group, L.P. | 397,808 | $1,213,314 | 0.01% |
| Laurion Capital Management LP | 522,900 | $1,594,845 | 0.01% |
| Schonfeld Strategic Advisors LLC | 326,702 | $996,441 | 0.01% |